Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands/Department of Clinical Neurophysiology and MEG center, Amsterdam Neuroscience, Amsterdam UMC and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Mult Scler. 2023 Jul;29(8):1001-1011. doi: 10.1177/13524585231159817. Epub 2023 Mar 25.
Suboptimal performance during neuropsychological testing frequently occurs in multiple sclerosis (MS), leading to unreliable cognitive outcomes. Neurophysiological alterations correlate with MS-related cognitive impairment, but studies have not yet considered performance validity.
To investigate neurophysiological markers of cognitive impairment in MS, while explicitly addressing performance validity.
Magnetoencephalography recordings, neuropsychological assessments, and performance validity testing were obtained from 90 MS outpatients with cognitive complaints. Spectral and resting-state functional connectivity (rsFC) properties were compared between cognitively impaired (CI), cognitively preserved (CP), and suboptimally performing (SUB) patients using regression models and permutation testing.
CI had higher power in low-frequency bands and lower power in high bands compared to CP, indicating neuronal slowing. CI also showed lower beta power compared to SUB. Overall power spectra visually differed between CI and CP, and SUB showed overlap with both groups. CI had lower rsFC than CP and SUB patients. CP and SUB patients showed no differences.
Neuronal slowing and altered rsFC can be considered cognitive markers in MS. Patients who performed suboptimally showed resemblance with patients with and without cognitive impairments, and although their overall neurophysiological profile was more similar to patients without impairments, it suggests heterogeneity regarding their pathophysiology.
多发性硬化症(MS)患者在神经心理学测试中经常表现不佳,导致认知结果不可靠。神经生理学改变与 MS 相关的认知障碍相关,但尚未考虑到表现的有效性。
研究多发性硬化症患者认知障碍的神经生理学标志物,同时明确考虑表现的有效性。
从 90 名有认知主诉的多发性硬化症门诊患者中获得脑磁图记录、神经心理学评估和表现有效性测试。使用回归模型和置换检验比较认知障碍(CI)、认知正常(CP)和表现不佳(SUB)患者的频谱和静息状态功能连接(rsFC)特性。
与 CP 相比,CI 具有较低的高频带功率和较高的低频带功率,表明神经元速度减慢。CI 还显示出比 SUB 更低的β功率。CI 和 CP 之间的总体功率谱在视觉上有所不同,而 SUB 则与这两个组都有重叠。CI 的 rsFC 低于 CP 和 SUB 患者。CP 和 SUB 患者之间没有差异。
神经元速度减慢和 rsFC 改变可以被认为是多发性硬化症的认知标志物。表现不佳的患者与有和没有认知障碍的患者相似,尽管他们的整体神经生理学特征与无损伤患者更相似,但这表明他们的病理生理学存在异质性。